In this session, you’ll learn how to:

-    Understand the initial assessment of the patient who presents with symptoms suggestive of ACS.
-    Understand the initial treatment differences in STEMI vs Non-STEMI.
-    Learn the potential causes of hemodynamic instability in the patient with ACS.

Robert M. Bender, DO, FACOI, Attending Cardiologist and Director Echo Lab, Central Maine Heart and Vascular Institute

In this session, you’ll learn how to:
-    Understand the clinical findings in patients with valve disease.
-    Know the indicators for considering valve intervention in patients with significant valve disease. 
-    Understand the pathophysiologic features of common congenital cardiac lesions. 

Robert M. Bender, DO, FACOI, Attending Cardiologist and Director Echo Lab, Central Maine Heart and Vascular Institute

In this session, you’ll learn how to:

-    Understand the importance of the clinical exam in the diagnosis of PAD.
-    Know the risk factors for PAD.
-    Know when to refer patients with PAD for advanced/non-medical intervention.

Robert M. Bender, DO, FACOI, Attending Cardiologist and Director Echo Lab, Central Maine Heart and Vascular Institute

In this session, you’ll learn:

-   Basic mechanisms.
-   Case questions
-   Guidelines and clinical correlations.

Robert J. Chilton, DO, MACOI, Professor of Medicine, University of Texas Health Science Center

In this session, you’ll learn:

-   Basic physiology.
-   Clinical case.
-   Guidelines and discussion.

Robert J. Chilton, DO, MACOI, Professor of Medicine, University of Texas Health Science Center

In this session, you'll learn how to:

• Define, classify and stage heart failure
• Discuss guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF)
• Discuss treatment for heart failure with preserved ejection fraction (HFpEF)
• Management of hospitalized patients and recognizing Stage D (advanced) heart failure

Christopher J. Sciamanna, DO, FACOI, Clinical Assistant Professor of Medicine, University of Illinois at Chicago

In this session, you'll learn how to:

• Review risk factors for atherosclerotic cardiovascular disease (ASCVD)
• Assess ASCVD risk and when to initiate statin therapy
• Review when to get and which stress test to use
• ECG must-knows
• Echo must-knows

Christopher J. Sciamanna, DO, FACOI, Clinical Assistant Professor of Medicine, University of Illinois at Chicago

In this session, you'll learn how to:

• Define and review classification of cardiomyopathy
• Discuss pathophysiology and clinical features of specific etiologies causing cardiomyopathy (focus on HCM, cardiac amyloid, myocarditis, stress CMP)
• Discuss treatment of specific cardiomyopathies

Christopher J. Sciamanna, DO, FACOI, Clinical Assistant Professor of Medicine, University of Illinois at Chicago

(55 mins)

In this session, you'll learn how to:

• Be able to differentiate the categories and subcategories of AKI
• Be able to differentiate the features acute vs chronic kidney disease
• Discuss treatments for AKI including fluid management and indications for dialysis

Mark D. Baldwin, DO, MACOI, FASN (he/him/his), Professor and Chair, Department of Primary Care Medicine, Arkansas Colleges of Health Education, College of Osteopathic Medicine

In this session, you'll:

• Compare and contrast the key clinical and diagnostic features of glomerular vs tubulointerstitial diseases
• Describe the renal manifestations of multiple myeloma
• Discuss the pathophysiology and treatment of hypercalcemia of malignancy

Mark D. Baldwin, DO, MACOI, FASN (he/him/his), Professor and Chair, Department of Primary Care Medicine, Arkansas Colleges of Health Education, College of Osteopathic Medicine

In this session, you'll learn how to: 

• Understand the clinical approach to proliferative glomerulonephritis
• Understand the value of renal biopsy
• Understand the workup for hematuria

John Prior, DO, FACOI (he/him/his), Nephrologist, NEPA Nephrology Associates

In this session, you'll learn how to:

• Discuss the key diagnostic features of Syndrome of inappropriate ADH secretion and appropriate treatments
• Explain the the key diagnostic features of central and nephrogenic diabetes insipidus and appropriate treatments
• Identify the key diagnostic features of Gitelman's and Bartter's syndromes

Mark D. Baldwin, DO, MACOI, FASN (he/him/his), Professor and Chair, Department of Primary Care Medicine, Arkansas Colleges of Health Education, College of Osteopathic Medicine

In session, you'll learn how to:

• Understand the approach to gapped metabolic acidosis
• Understand the use of the urine anion gap
• Understand the diagnosis and treatment approach to metabolic alkalosis

John Prior, DO, FACOI (he/him/his), Nephrologist, NEPA Nephrology Associates

In this session, you'll learn how to:

• Understand of guideline based treatment for hypertension
• Understand the place of the SPRINT Trial in relation to hypertension treatment goals
• Understand the workup for hypertension

John Prior, DO, FACOI (he/him/his), Nephrologist, NEPA Nephrology Associates